Drawing for NMDP

USPTO serial 97863742

NMDP

Reviewed by CopyMark Law Group

Reg. 8170083Status 700Registered
Filing date
Status date
Registration date
Mar 10, 2026
Examiner
BURCH, JILLIAN RENEE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NMDP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kourtney A. Mulcahy

Kourtney A. Mulcahy AKERMAN LLP777 SOUTH FLAGLER DRIVESUITE 1100 WEST TOWERWEST PALM BEACH, FL 33401

Goods and services

ClassDescriptionStatusFirst use
001Biological tissue, namely, bone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for scientific research use, namely, for developing new cellular therapies and other treatmentsACTIVE—
005Biological tissue, namely, bone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for medical purposesACTIVE—
035Logistics management in the medical field, namely, management and coordination of medical services related to bone marrow and stem cell donation; Transportation logistics services, namely, arranging for the transportation of goods for others, particularly of products and samples from a collection site to entities who are developing new cellular therapies and other treatments related to bone marrow and peripheral blood stem cells; Charitable services, namely, organizing and conducting volunteer programs and community service projects related to bone marrow, peripheral blood stem cells and cord blood donation; Promoting awareness of the need for bone marrow, peripheral blood stem cells and cord blood donation; Maintaining and operating a central bone marrow registry for use in matching potential donors and recipients for bone marrow and hematopoietic stem cell transplant; Promoting awareness of the need for bone marrow donors by organizing and conducting bone marrow donor registry drives being volunteer programs and community service projects to increase registered donorsACTIVE—
036Charitable fundraising services, namely, raising funds for bone marrow, peripheral blood stem cells and cord blood research, transplant services, educational programs and donor recruitment; Providing financial assistance to patients and their families in the need of bone marrow, peripheral blood stem cells and cord blood transplantsACTIVE—
041Educational and training services, namely, providing seminars, workshops, conferences, classes, lectures and presentations in the field of stem cells, stem cell research and stem cell applications and cellular therapies and distribution of course and educational materials in connection therewith; On-line electronic newsletters delivered by email in the field of stem cell, cord blood and bone marrow donationsACTIVE—
042Providing medical research services for developing new cellular therapies and other treatments in the field of bone marrow and peripheral blood stem cells; Gene therapy researchACTIVE—
044Providing a website featuring healthcare information on stem cell and bone marrow donor recruitment and donation; Providing an Internet website portal featuring information relating to bone marrow transplant procedures; Providing information in field of cellular therapies, bone marrow and hematopoietic stem cell transplants and stem cell therapy services; Stem cell therapy servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 10, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 10, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 19, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 19, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 19, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 19, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 19, 2026ALIEASSIGNED TO LIE—
Feb 10, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Nov 7, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Aug 11, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2025CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 28, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 26, 2025IUAFUSE AMENDMENT FILED—
Mar 26, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 2, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 2, 2024EX1GSOU EXTENSION 1 GRANTED—
Oct 2, 2024EXT1SOU EXTENSION 1 FILED—
Oct 2, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 6, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 28, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 28, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Dec 28, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 28, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 28, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 26, 2023DOCKASSIGNED TO EXAMINER—
Apr 21, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 3, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance